February 1, 2017

Falanx Group Ltd Q&A with CEO Stuart Bladen & New Executive Director Jay Abbott (LON:FLX)

Falanx Group Ltd (LON:FLX) Chief Executive Officer Stuart Bladen and Executive Director Jay Abbott caught up with DirectorsTalk for an exclusive interview to discuss their three..

Epwin Group PLC FY16 in line with expectations, delivering c.19% earnings growth – Zeus Capital

Epwin Group PLC (LON:EPWN) year-end trading update states that results are in line with expectations which we take to be in line with consensus PBT forecasts..

Savannah Resources Plc Ravene Drilling Programme Completed at Mutamba Project

Savannah Resources plc (LON:SAV), announced today that it has completed drilling at the Ravene deposit in Mozambique (Figures 1-3 – See PDF), which forms part of..

Allergy Therapeutics plc Good Polyvac® Peanut preclinical results – Zeus Capital

Allergy Therapeutics Plc (LON:AGY) is a UK-based, specialty pharmaceutical company focused on the development, manufacture and sale of vaccines and other products for the treatment and..

Quantum Pharma PLC Pre-close trading update – on plan

Quantum Pharma plc (LON:QP), the service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors, has released a pre-close trading update this morning...

Search

Funds

February 1, 2017

Search

Funds

February 1, 2017

FTSE 100

Funds